ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SPNC The Spectranetics Corp. (MM)

38.45
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
The Spectranetics Corp. (MM) NASDAQ:SPNC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 38.45 38.45 38.50 0 01:00:00

Spectranetics to Present at the UBS Global Healthcare Conference

11/05/2016 9:00pm

GlobeNewswire Inc.


The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more The Spectranetics Corp. (MM) Charts.

The Spectranetics Corporation (NASDAQ:SPNC) today announced that Chief Financial Officer Stacy McMahan will be presenting at the UBS Global Healthcare Conference on May 25th, 2016, at the Grand Hyatt in New York City.

The presentation will begin at 9:00 am EST. Interested parties can access the live audio webcast at https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=82_6JDNC28. An archived presentation will be available on Spectranetics’ Investor Relations website for 30 days.

About Spectranetics

The Spectranetics Corporation develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are available in over 65 countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads.

The Company's Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee, the AngioSculpt scoring balloon used in both peripheral and coronary procedures, and the Stellarex drug-coated balloon peripheral angioplasty platform, which received European CE mark approval in December 2014. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart.

The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com.

Investor Relations Contacts:

Zach Stassen                                                                                       
Sr. Director of Finance                                                                        
zach.stassen@spnc.com                                                                     
(719) 447-2292                                                                                  

Michaella Gallina
Director of Investor Relations
michaella.gallina@spnc.com
(719) 447-2417

1 Year The Spectranetics Corp. (MM) Chart

1 Year The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

Your Recent History

Delayed Upgrade Clock